SANUWAVE Health, Inc. (SNWV)
NASDAQ: SNWV · Real-Time Price · USD
34.40
-0.43 (-1.23%)
At close: Sep 26, 2025, 4:00 PM EDT
34.60
+0.20 (0.58%)
After-hours: Sep 26, 2025, 4:22 PM EDT
SANUWAVE Health Market Cap
SANUWAVE Health has a market cap or net worth of $294.74 million as of September 26, 2025.
Market Cap
294.74M
Enterprise Value
314.20M
1-Year Change
n/a
Ranking
Category
Stock Price
$34.40
Market Cap Chart
Since March 7, 2025, SANUWAVE Health's market cap has increased from $247.50M to $294.74M, an increase of 19.09%. That is a compound annual growth rate of 36.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 294.70M | -1.24% |
| Sep 25, 2025 | 298.40M | -3.05% |
| Sep 24, 2025 | 307.80M | 4.94% |
| Sep 23, 2025 | 293.30M | -3.04% |
| Sep 22, 2025 | 302.50M | 1.20% |
| Sep 19, 2025 | 298.90M | -0.60% |
| Sep 18, 2025 | 300.70M | -0.96% |
| Sep 17, 2025 | 303.60M | 3.90% |
| Sep 16, 2025 | 292.20M | -4.13% |
| Sep 15, 2025 | 304.80M | -3.79% |
| Sep 12, 2025 | 316.80M | -0.13% |
| Sep 11, 2025 | 317.20M | 5.28% |
| Sep 10, 2025 | 301.30M | -2.55% |
| Sep 9, 2025 | 309.20M | 0.45% |
| Sep 8, 2025 | 307.80M | -5.18% |
| Sep 5, 2025 | 324.60M | -1.96% |
| Sep 4, 2025 | 331.10M | -0.42% |
| Sep 3, 2025 | 332.50M | -2.38% |
| Sep 2, 2025 | 340.60M | -4.54% |
| Aug 29, 2025 | 356.80M | -1.87% |
| Aug 28, 2025 | 363.60M | -4.29% |
| Aug 27, 2025 | 379.90M | 5.59% |
| Aug 26, 2025 | 359.80M | -1.56% |
| Aug 25, 2025 | 365.50M | -5.21% |
| Aug 22, 2025 | 385.60M | 9.08% |
View and export this data all the way back to 2025. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |